Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster study of DTPa-HBV-IPV/Hib-MenC-TT in toddlers previously primed with the same vaccine
2010-019253-18Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2010
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio/Haemophilus influenzae type b-meningococcal C-tetanus toxoid vaccine, pertussis filamentous haemagglutinin and Meningococcal group C polysaccharide conjugate vaccine in diphtheria, Tetanus, pertussis and 4 more (2 arms), sponsored by GSK. Primary endpoints: Immune response to the study vaccine antigens, Non-inferiority for seroprotection and pertussis antibody concentrations and 1 more. Started Jun 2010; status: completed.
02
Drugs
diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio/Haemophilus influenzae type b-meningococcal C-tetanus toxoid vaccinepertussis filamentous haemagglutininMeningococcal group C polysaccharide conjugate vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on 2010-019253-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019253-18.